Increased risk for renal cell carcinoma in end stage renal disease – a population-based case-control study

References

• Kramer A, Pippias M, Noordzij M, et al. The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) registry annual report 2016: a summary. Clin Kidney J. 2019;12(5):702–720.
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–924.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387.
   PubMed Web of Science ®Google Scholar
• National Swedish Kidney Cancer Register, 2020 update. Available from: https://www.cancercentrum.se/samverkan/cancerdiagnoser/urinvagar/njurcancer/kvalitetsregister/.
   Google Scholar
• Thorstenson A, Bergman M, Scherman-Plogell AH, et al. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the national Swedish kidney cancer register. Scand J Urol. 2014;48(3):231–238. Jun
   PubMed Web of Science ®Google Scholar
• Thorstenson A, Harmenberg U, Lindblad P, et al. Cancer characteristics and current treatments of patients with renal cell carcinoma in Sweden. Biomed Res Int. 2015;2015:456040.
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Takagi T, Kondo T, et al. Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population. Int J Clin Oncol. 2015;20(5):1035–1041. Oct
   PubMed Web of Science ®Google Scholar
• Breda A, Lucarelli G, Rodriguez-Faba O, et al. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. World J Urol. 2015;33(1):1–7.
   PubMed Web of Science ®Google Scholar
• Tsuzuki T, Iwata H, Murase Y, et al. Renal tumors in end-stage renal disease: a comprehensive review. Int J Urol. 2018;25(9):780–786.
   PubMed Web of Science ®Google Scholar
• Neuzillet Y, Tillou X, Mathieu R, et al. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol. 2011;60(2):366–373.
   PubMed Web of Science ®Google Scholar
• Shrewsberry AB, Osunkoya AO, Jiang K, et al. Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis. Clin Transplant. 2014;28(2):211–216.
   PubMed Web of Science ®Google Scholar
• Van Poppel H, Nilsson S, Algaba F, et al. Precancerous lesions in the kidney. Scand J Urol Nephrol Suppl. 2000; 34(6):136–165.
   Google Scholar
• Ishikawa I, Saito Y, Asaka M, et al. Twenty-year follow-up of acquired renal cystic disease. Clin Nephrol. 2003;59(3):153–159.
   PubMed Web of Science ®Google Scholar
• Kondo T, Sasa N, Yamada H, et al. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study. Pathol Int. 2018;68(10):543–549.
   PubMed Web of Science ®Google Scholar
• Schwarz A, Vatandaslar S, Merkel S, et al. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. CJASN. 2007;2(4):750–756.
   PubMed Web of Science ®Google Scholar
• Gigante M, Neuzillet Y, Patard JJ, et al. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities? BJU Int. 2012;110(11b):E570–E573.
   PubMedGoogle Scholar
• Song C, Hong SH, Chung JS, et al. Renal cell carcinoma in end-stage renal disease: multi-institutional comparative analysis of survival. Int J Urol. 2016;23(6):465–471.
   PubMed Web of Science ®Google Scholar
• Landberg A, Lindblad P, Harmenberg U, et al. The renal cell cancer database Sweden (RCCBaSe) – a new register-based resource for renal cell carcinoma research. Scand J Urol. 2020;54(3):235–240.
   PubMed Web of Science ®Google Scholar
• Landberg A, Bruce D, Lindblad P, et al. Validation of data quality in the National Swedish Kidney Cancer Register. Scand J Urol. 2021;1–7.
   PubMed Web of Science ®Google Scholar
• StataCorp. Stata: release 16. Statistical software. College Station (TX): TSCL; 2019.
   Google Scholar
• Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101–121.
   PubMedGoogle Scholar
• Ce DP. Estimating and modeling relative survival. Stata J. 2015;15(1):186–215.
   Web of Science ®Google Scholar
• Hurst FP, Jindal RM, Fletcher JJ, et al. Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients. Urology. 2011;77(6):1271–1276.
   PubMed Web of Science ®Google Scholar
• Karami S, Yanik EL, Moore LE, et al. Risk of renal cell carcinoma among kidney transplant recipients in the United States. Am J Transplant. 2016;16(12):3479–3489. Dec
   PubMed Web of Science ®Google Scholar
• Billis A, Freitas LLL, Costa LBE, et al. Genitourinary malignancies in transplant or dialysis patients: the frequency of two newly described 2016 World Health Organization histopathologic types. Transplant Proc. 2017;49(8):1783–1785. Oct
   PubMed Web of Science ®Google Scholar
• Goh A, Vathsala A. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transplant. 2011;11(1):86–92.
   PubMedGoogle Scholar
• Hidayat K, Du X, Zou SY, et al. Blood pressure and kidney cancer risk: meta-analysis of prospective studies. J Hypertens. 2017;35(7):1333–1344. Jul
   PubMed Web of Science ®Google Scholar
• Klein JA, Gonzalez SA, Fischbach BV, et al. Routine ultrasonography surveillance of native kidneys for renal cell carcinoma in kidney transplant candidates. Clin Transplant. 2016;30(8):946–953.
   PubMed Web of Science ®Google Scholar
• Chen K, Huang HH, Aydin H, et al. Renal cell carcinoma in patients with end-stage renal disease is associated with more favourable histological features and prognosis. Scand J Urol. 2015;49(3):200–204.
   PubMed Web of Science ®Google Scholar
• van Walraven C, Manuel DG, Knoll G. Survival trends in ESRD patients compared with the general population in the United States. Am J Kidney Dis. 2014;63(3):491–499.
   PubMed Web of Science ®Google Scholar